Trial intelligence / Profile preview

Optimizing Pediatric Acute Diarrhoeal Disease Management in Botswana

NCT02803827Phase 3Completed

Sponsor
Hamilton Health Sciences
Start
Jun 2016
Primary completion
Jan 2019
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 3 trial of Lactobacillus reuteri DSM 17938 in acute gastroenteritis, sponsored by Hamilton Health Sciences. Started Jun 2016; status: completed.

02

Drugs

Lactobacillus reuteri DSM 17938
03

Conditions

acute gastroenteritis

Beyond the preview

Go deeper on NCT02803827.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02803827.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call